Back to search

Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia

Data up to Jan 2025

Published2003
Citations496
References31

Total Citations Per Year

Abstract

References (31)

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia

1988 • 2,380 citations

Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

1997 • 1,431 citations

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1991 • 1,298 citations

Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

1998 • 1,220 citations

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins

1996 • 843 citations

United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia

2001 • 825 citations

Acute Promyelocytic Leukemia

2015 • 764 citations

Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy

1997 • 492 citations

A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients

1991 • 412 citations

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia

2000 • 258 citations

Therapy of Molecular Relapse in Acute Promyelocytic Leukemia

1999 • 242 citations

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

2001 • 242 citations

Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.

1999 • 228 citations

Arsenic Trioxide and Melarsoprol Induce Programmed Cell Death in Myeloid Leukemia Cell Lines and Function in a PML and PML-RAR Independent Manner

1998 • 228 citations

Genetic Diagnosis and Molecular Monitoring in the Management of Acute Promyelocytic Leukemia

1999 • 219 citations

Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo

2001 • 205 citations

Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.

2000 • 191 citations

Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro

1999 • 188 citations

The unique aspects of acute promyelocytic leukemia.

1990 • 183 citations

Experience with gemtuzumab ozogamycin (“mylotarg”) and all-trans retinoic acid in untreated acute promyelocytic leukemia

2002 • 176 citations

Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide

2001 • 170 citations

The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms

1998 • 159 citations

Molecular Remissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly Diagnosed Acute Promyelocytic Leukemia

1999 • 106 citations

All- trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study

1997 • 74 citations

Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines

1999 • 70 citations

Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid

1996 • 68 citations

Arsenicals in hematologic cancers.

2000 • 57 citations

Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.

1998 • 50 citations

All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia

1994 • 44 citations

Novel therapeutic agents for the treatment of myelodysplastic syndromes.

2000 • 44 citations

Retinoic Acid Syndrome Induced by Arsenic Trioxide in Treating Recurrent All-Trans Retinoic Acid Resistant Acute Promyelocytic Leukemia

2000 • 34 citations

Cited By (0)

No citing papers found in database

Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic… (2003) – Cancer | Metascience Observatory Explorer